Dr Lal Pathlabs one of the largest players of healthcare industry in India has a beaten down stock price currently. It is approximately 53.29% down from it's lifetime high. There is not a single reason for such stock price. The company is posting good results and is consistently showing profits. But the stock is highly undervalued. It is a good time to buy it as...
krsnaa is looking good now
If there is a slight bounce from 600, it looks like it could go to 650 to 690.
If it breaks the major level of 600, then it seems that it can go up to 530 comfortably
A major fib level of 726 is coming which after breaking it can start an uptrend (which doesn't seem to break in this scenario.)
We have tried to give some view on this...
Dr Lal PathLabs net profit zooms 54% to Rs 81.3 crore in Q3. Yet the stock is consolidating in the same place for a week, even NSE:CNXPHARMA is trading at the ATH. This might be a very good chance to enter at below price of 2400 (2394) with 1.5% stoploss.
📊 Script: LALPATHLAB (DR. LAL PATH LABS LTD.)
📊 Nifty50 Stock: NO
📊 Sectoral Index: NIFTY PHARMA / NIFTY500 / NIFTY MIDCAP
📊 Sector: Healthcare
📊 Industry: Healthcare Service Provider
Key highlights: 💡⚡
📈 Script is trading at upper band of Bollinger Bands (BB) and it may give breakout of it.
📈 MACD is giving crossover.
📈 Double Moving Averages may also give...
Targets 3478 and 3997 as the 3rd Wave arrives
Good Fundamentals:
High Management Efficiency with a high ROE of 22.80%
Company has a low Debt to Equity ratio (avg) at -0.79 times
With a growth in Net Profit of 161.04%, the company declared Very Positive results in Mar 21
The company has declared positive results for the last 2 consecutive quartersPBT LESS OI(Q) At...
AB=CD Harmonic
Rounding bottom breakout today
2300ish is turning out to be a solid support
4hr TF Swing position
#Learning n sharing my view not an advise
#DRLAL LONG
